Rocket Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
/ 
Frequently asked questions
To buy Rocket Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Rocket Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Rocket Pharmaceuticals Inc. is RCKT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Rocket Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Rocket Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Rocket Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Rocket Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Rocket Pharmaceuticals Inc..